Shantha Biotechnics' Acquisition

Shantha Biotechnics was acquired by Sanofi Pasteur on November 06, 2013.

Shantha Biotech is engaged in the production and commercialization of vaccines against Hepatitis B, Tetanus, Diphtheria, Pertussis, Haemophilus Influenza Type B, and Cholera, as well as recombinant Er…

Articles about Shantha Biotechnics' Acquisition: